X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

RVPHW

Closed

Reviva Pharmaceuticals Holdings Inc

0.0234
0.0000 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.0234
Day's Range: 0.0232 - 0.0283
Send
When Written:
 
1.04
Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company that focuses on developing and commercializing innovative therapies for unmet medical needs in areas such as neurology, oncology, and metabolic diseases. The company's lead candidate is RP5063, a novel small molecule that is being developed for the treatment of schizophrenia and bipolar disorder. RP5063 has demonstrated promising results in Phase 2 clinical trials, and the company is currently preparing for Phase 3 trials. Reviva Pharmaceuticals Holdings Inc is headquartered in San Francisco, California, and was founded in 2010.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X